Fisher Scientific International reported it's third quarter
performance for 2005, which revealed profit had more than doubled
as a result of improved sales and fewer acquisition related
charges.
AssurX have launched a software process for document control, which
will enable pharmaceutical manufacturing companies to streamline
their approach to monitoring safety issues and overall quality
control efforts.
pSivida has signed a licensing agreement with Beijing's Med-Pharm,
in a move that will facilitate distribution of BrachySil in China -
the world's fastest growing market for pharmaceuticals.
Troubled firm Flamel reported a sharp decrease in total third
quarter revenues - $3.1 million (€2.6 million), compared to $13.3
million this time last year - resulting in a net loss $11.9
million.
A federal US judge set a precedent last week in ruling against the
US Food & Drug Administration (FDA) in a four-year dispute
against Utah Medical Products.
Penn Pharmaceutical Services has reported strong sales figures for
the fifth consecutive year, with a key driver of recent growth
being attributed to a boom in contract manufacturing as well as
small-scale commercial batches.
Cambrex has recorded a gain in the third quarter of this year, with
growth in its Bioproducts and Human Health segments. The company's
troublesome BioPharma division continues to underperform,
indicative of a market for outsourced...
Cardinal Health reported a varied first quarter, with sales and
income receiving substantial gains due to across-the-board
improvement in pharmaceutical distribution, medical products and
services and clinical technologies.
Arsenal Capital Partners has acquired a majority stake in Reilly
Industries for €209 million and Velsicol Chemical for an
undisclosed fee. The purchases continue a rich vein of activity for
the private equity firm, which now hold...
Par Pharmaceuticals has announced a collaboration with MN
Pharmaceuticals to develop and market generic versions of
injectable pharmaceuticals in which Par enters a new market
segment.
Millipore, a maker of purification systems used in drug
manufacturing, reported lower third-quarter profit due to
acquisition-related tax charges and manufacturing consolidation
costs.
Drug packaging maker West Pharmaceutical Services release its 3Q
results, which indicate a rise in profits but fell short of analyst
estimates, due to slow sales in some segments and high raw material
and energy costs.
Bruker AXS, a subsidiary of the Bruker BioSciences Corporation, has
announced an agreement to purchase Roentec, an x-ray microanalysis
instrumentation company that signals Bruker's intention to
reinforce its standing within this...
Actavis's $810 million (€677 million) cash acquisition of
Alpharma's US and international generic drugs division is part of
the firm's strategy to become one of the global leaders in the
sector.
